This research explores Immune checkpoint inhibitors in melanoma, contributing new insights to the field of Medicine & Biology.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via OpenAlex.
| Category | 🧬 Medicine & Biology |
| Published | Sep 01, 2021 |
| Journal | The Lancet |
| Authors | Matteo S. Carlino, James Larkin, Georgina V. Long |
| DOI | 10.1016/s0140-6736(21)01206-x |
| Citations | 1,182 |
| Source | OpenAlex |